To map the 5’ end of this larger ERCC1 variant, we performed 5’ RACE assay on the ovarian cancer cells using the ERCC1 specific reverse primers from upstream of the normal transcriptional start site. The gene discussed is ERCC1; the disease is ovarian carcinoma.